Viyash Scientific Q2 FY27: revenue up 133.0% to ₹988 Cr, net profit up 288.6% to ₹76 Cr
Results · 14 Nov 2026 · Viyash Scientific (VIYASH)
| Q2 FY27 | ₹ Cr | YoY |
|---|---|---|
| Revenue | 988 | +133.0% |
| Operating profit | 165 | +196.2% |
| Net profit | 76 | +288.6% |
In Q2 FY27, revenue rose 16.2% YoY to INR 988 crores, pre-ESOP EBITDA reached INR 208 crores at a 21.1% margin, and PAT grew 16.1% YoY to INR 85 crores.
For H1 FY27, revenue increased 17.8% YoY to INR 1,934 crores with a 21.3% pre-ESOP EBITDA margin, net debt dropped to INR 26 crores, and the BioForLife acquisition closed on October 1, 2026.
Management expects overall FY27 PAT to grow more than 50%, full-year capex of INR 140-150 crores, and gross margins to stay around 54%-55% this year and next.
Company page · Results tracker
Anand Ganapathy K | SEBI Registered Research Analyst | INH000016630.